WeightWatchers

🚀 #WeightHealth is entering a new era in 2026. As we look ahead to next year, four forces will shape what's next in the industry: GLP-1s, AI, Longevity and Cost Controls. 🔗 Read how these forces will shape weight health and how organizations can implement creative solutions to help future-proof their benefits strategies, control costs, and improve holistic health:  https://lnkd.in/eTwfw2SR #employeehealth #healthplans #benefitsstrategy #healthcareinnovation #futureofhealth

🚨 News Alert! #WeightWatchers was included in STAT's in-depth look at how pharmaceutical companies like #NovoNordisk are increasingly partnering with telehealth platforms to drive access to and demand for #GLP1 medications In the piece, our Chief Commercial Officer Scott Honken spotlights how our collaboration with Novo Nordisk delivers value for WeightWatchers members, from integrated account access and bundled pricing to inventory visibility and shipment tracking. He also shares that we’re gearing up to support the launch of Novo's Wegovy pill. As demand for GLP-1s accelerates, this story underscores WeightWatchers’ role as a go-to partner for pharma and our commitment to making these medications more accessible and affordable for those who need them. 🔗 Read more from #STAT here: https://lnkd.in/eg8q6kFD

The No. 1 thing people tell us holds them back from #GLP1s? Cost. Today that changes. #WeightWatchers is offering a new, lower cash-pay price for Wegovy and Ozempic, made possible through our ongoing #collaboration with #NovoNordisk. Wegovy injection 0.25 mg and 0.5 mg, and Ozempic are now available at a limited time price of $199 per month for self-pay WeightWatchers Clinic members between now and March 31, 2026. This introductory offer is good for the first two months. These medications are offered through WeightWatchers Clinic, which brings board-certified clinicians, registered dietitians and fitness specialists, together with WeightWatchers’ behavioral and nutritional program, and the strength of our community. Access matters. Results matter. And we're committed to delivering both.

🇬🇧 Earlier this week, we hosted an intimate breakfast in #London with an incredible group of influential journalists. #WeightWatchers CEO Tara Comonte and Chief Medical Officer Kim Boyd, MD opened the conversation with a powerful look at WeightWatchers’ evolution and what’s ahead. The discussion also highlighted WeightWatchers for Menopause, the first-of-its-kind program delivering truly comprehensive care—bringing together specialized medical expertise, science-backed nutrition, lifestyle tools, and a compassionate community. What followed was an honest, thoughtful dialogue about health, weight, stigma, and the changing needs of midlife women. We're grateful for this meaningful discussion, the openness in the room, and the shared commitment to helping women feel seen, supported, and empowered. ✨ #weighthealth #menopause #GLP1s #HRT

✨ We’re shaping a more empathetic, stigma-free dialogue around #weighthealth and #GLP1s. ✨ #Bustle’s in-depth feature, “The GLP-1 Secret Society,” explores why some people are still hesitant to talk openly about using GLP-1s medications for weight management. As our Chief Experience Officer Julie Rice shares, attitudes toward GLP-1s are shifting rapidly. While some people may still feel reluctant to share their experience, Julie notes we’re on the cusp of a cultural shift, one defined by openness and acceptance. At #WeightWatchers, we’re proud to be part of that shift. As Julie notes in the story, through our 20,000+ workshops each month, we’re helping normalize these conversations and providing community and support for members using GLP-1s as part of their health journey. 🔗 Read the full story in #Bustle: https://lnkd.in/e4dvm5dY

🇩🇪 Two days, two cities, one conversation that matters. With the launch of WeightWatchers for Menopause in #Germany, we gathered editors, creators, and cultural voices in both #Hamburg and #Munich to spark a conversation that still too often remains quiet, despite touching nearly every woman’s life. Alongside #WeightWatchers CEO Tara Comonte and Chief Medical Officer Kim Boyd, MD, author and podcast host Stephanie Hielscher and Heyday Magazine Founder Stephanie Neubert, we explored what it takes to truly strengthen #WomensHealth: knowledge, awareness, community, and offerings that meet women where they are. Thank you to everyone who joined, listened, and shared. By speaking openly about #menopause and #weighthealth, and by creating supportive spaces like these, we’re helping make women’s health visible, prioritized, and empowered. This is only the begining. ✨ *** 🇩🇪 Mit dem Launch von „WeightWatchers für die Menopause“ haben wir in Hamburg und München Redakteurinnen und Multiplikatorinnen zusammengebracht, um über eine Lebensphase zu sprechen, die noch zu oft leise bleibt – obwohl sie so viele betrifft. Gemeinsam mit Tara Comonte (CEO WeightWatchers), Dr. Kim Boyd (Chief Medical Officer WeightWatchers), Stephanie Hielscher (Podcasterin & Autorin) und Stephanie Neubert (Gründerin der Frauenplattform Heyday) haben wir darüber gesprochen, wie wir Frauengesundheit stärken können: durch Wissen, Haltung, Community und Angebote, die wirklich unterstützen. Danke an alle, die ihre Perspektiven geteilt haben und das Thema weitertragen – und damit helfen, es sichtbar in den öffentlichen Diskurs zu bringen. Es braucht Räume wie diese und wir freuen uns darauf, sie gemeinsam weiter zu gestalten. ✨

ICYMI, the FDA has requested the removal of the long-standing black box warning on estrogen and other hormone therapies for #menopause. As our Chief Medical Officer Kim Boyd, MD notes, this opens the door for more women to access treatments that are safe and effective when started under age 60 or within 10 years of menopause, not only easing symptoms like hot flashes, weight gain, and sleep disruption, but also helping prevent osteoporosis, heart disease, and even dementia. At #WeightWatchers, we’re encouraged to see science and policy align to better support women at midlife. WeightWatchers for Menopause is the first-of-its-kind comprehensive program, combining clinical expertise, behavioral support, and community to help women navigate this phase with confidence. #WomensHealth #MenopauseCare

#WeightWatchers Chief Marketing Officer Michael Amsel and Chief Financial Officer Felicia DellaFortuna joined Brand Innovators to discuss the power of the #CMO-#CFO relationship and how they are redefining growth. 📈 For Mike and Felicia, growth is about connection and purpose. As Mike shared, “So much of our growth comes from unlocking value in what’s already within our community. We’re empowering our members, coaches and clinicians to tell their stories and drive connection.”  Felicia added, “Anyone can drive growth for a moment, but sustainable growth means staying true to your purpose—even as the landscape shifts around you.” From navigating massive industry shifts, including entering the #GLP1 landscape, to emerging stronger post-reorganization and launching new products like WeightWatchers for Menopause, the conversation underscored what’s fueling WeightWatchers’ next chapter. Mike and Felicia also spoke about the power of partnership between #finance and #marketing, noting that a shared conviction and constant communication enable bold ideas to take shape at the company. This alignment has been core to WeightWatchers’ #transformation as we continue building a future that combines cutting-edge technology, clinical expertise and community.

#ObesityWeek2025 is here! We’re excited to share new research from WeightWatchers demonstrating real-world, sustained results with anti-obesity medications. The new data presented showcases that WeightWatchers Clinic members using anti-obesity medications sustained an average 20% body-weight reduction at 24 months when delivered with WeightWatchers' comprehensive behavioral and clinical support. As leaders in evidence-based weight management, highlighting this research at ObesityWeek is an honor and testament to our commitment to advancing science and building the most trusted, outcomes-driven platform for long-term health. *Based on observational study of 4,317 WW Clinic members who initiated anti-obesity medication treatment through WW Clinic between January 2022–December 2024. Ruddiman et al. Twenty-four month outcomes from a real-world telehealth obesity treatment clinic using anti-obesity medications. Manuscript under review.

One of the top pickleball players spreading the joy of movement and community—two things we believe in deeply at #WeightWatchers. 💙 We loved bringing pickleball to the #HLTHUSA conference in Las Vegas and showing how fun, connection, and health can go hand in hand—on and off the court.